FDA approves new low-dose birth control pill

A new birth control pill, called LoSeasonique, has just been approved for sale in the US by the FDA, according to Barr Pharmaceuticals.

Under the LoSEASONIQUE(R) extended-cycle regimen, women take combination tablets containing 0.10 mg levonorgestrel/0.02 mg of ethinyl estradiol daily for 84 consecutive days, followed 0.01 mg ethinyl estradiol tablets for seven days. The regimen is designed to reduce the number of withdrawal bleeding periods from 13 to four per year.

LoSeasonique is a low-dose version of Seasonique, which also reduces the number of periods a woman has.
What do you all think about these period-reducing birth control pills? Anyone tried them?

Join the Conversation